• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常血糖性糖尿病酮症酸中毒:漏诊情况

Euglycemic diabetic ketoacidosis: A missed diagnosis.

作者信息

Nasa Prashant, Chaudhary Sandeep, Shrivastava Pavan Kumar, Singh Aanchal

机构信息

Department of Critical Care Medicine, NMC Specialty Hospital, Dubai 7832, United Arab Emirates.

Department of Endocrinology, NMC Specialty Hospital, Dubai 7832, United Arab Emirates.

出版信息

World J Diabetes. 2021 May 15;12(5):514-523. doi: 10.4239/wjd.v12.i5.514.

DOI:10.4239/wjd.v12.i5.514
PMID:33995841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8107974/
Abstract

Euglycemic diabetic ketoacidosis (DKA) is an acute life-threatening metabolic emergency characterized by ketoacidosis and relatively lower blood glucose (less than 11 mmol/L). The absence of hyperglycemia is a conundrum for physicians in the emergency department and intensive care units; it may delay diagnosis and treatment causing worse outcomes. Euglycemic DKA is an uncommon diagnosis but can occur in patients with type 1 or type 2 diabetes mellitus. With the addition of sodium/ glucose cotransporter-2 inhibitors in diabetes mellitus management, euglycemic DKA incidence has increased. The other causes of euglycemic DKA include pregnancy, fasting, bariatric surgery, gastroparesis, insulin pump failure, cocaine intoxication, chronic liver disease and glycogen storage disease. The pathophysiology of euglycemic DKA involves a relative or absolute carbohydrate deficit, milder degree of insulin deficiency or resistance and increased glucagon/insulin ratio. Euglycemic DKA is a diagnosis of exclusion and should be considered in the differential diagnosis of a sick patient with a history of diabetes mellitus despite lower blood glucose or absent urine ketones. The diagnostic workup includes arterial blood gas for metabolic acidosis, serum ketones and exclusion of other causes of high anion gap metabolic acidosis. Euglycemic DKA treatment is on the same principles as for DKA with correction of dehydration, electrolytes deficit and insulin replacement. The dextrose-containing fluids should accompany intravenous insulin to correct metabolic acidosis, ketonemia and to avoid hypoglycemia.

摘要

正常血糖性糖尿病酮症酸中毒(DKA)是一种急性危及生命的代谢急症,其特征为酮症酸中毒且血糖相对较低(低于11 mmol/L)。无高血糖现象对于急诊科和重症监护病房的医生而言是个难题;这可能会延误诊断和治疗,导致更糟的后果。正常血糖性DKA是一种不常见的诊断,但可发生于1型或2型糖尿病患者。随着糖尿病管理中加入钠/葡萄糖协同转运蛋白-2抑制剂,正常血糖性DKA的发病率有所增加。正常血糖性DKA的其他病因包括妊娠、禁食、减肥手术、胃轻瘫、胰岛素泵故障、可卡因中毒、慢性肝病和糖原贮积病。正常血糖性DKA的病理生理学涉及相对或绝对的碳水化合物缺乏、较轻程度的胰岛素缺乏或抵抗以及胰高血糖素/胰岛素比值增加。正常血糖性DKA是一种排除性诊断,对于有糖尿病病史的患病患者,尽管血糖较低或尿酮阴性,在鉴别诊断时也应考虑。诊断检查包括检测动脉血气以判断是否存在代谢性酸中毒、血清酮,并排除其他导致高阴离子间隙代谢性酸中毒的病因。正常血糖性DKA的治疗原则与DKA相同,即纠正脱水、电解质缺乏并补充胰岛素。含葡萄糖的液体应与静脉胰岛素一同使用,以纠正代谢性酸中毒、酮血症并避免低血糖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceef/8107974/05fd3d58473f/WJD-12-514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceef/8107974/05fd3d58473f/WJD-12-514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceef/8107974/05fd3d58473f/WJD-12-514-g001.jpg

相似文献

1
Euglycemic diabetic ketoacidosis: A missed diagnosis.正常血糖性糖尿病酮症酸中毒:漏诊情况
World J Diabetes. 2021 May 15;12(5):514-523. doi: 10.4239/wjd.v12.i5.514.
2
Euglycemic Diabetic Ketoacidosis: A Review.正常血糖性糖尿病酮症酸中毒:综述
Curr Diabetes Rev. 2017;13(3):315-321. doi: 10.2174/1573399812666160421121307.
3
"Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.钠-葡萄糖协同转运蛋白2抑制剂使用引发的“正常但灾难性”的正常血糖性糖尿病酮症酸中毒:一例报告
Cureus. 2023 Nov 22;15(11):e49236. doi: 10.7759/cureus.49236. eCollection 2023 Nov.
4
A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂诱发正常血糖性糖尿病酮症酸中毒治疗前景的文献综述
Cureus. 2022 Sep 27;14(9):e29652. doi: 10.7759/cureus.29652. eCollection 2022 Sep.
5
Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.自我诱导的正常血糖性糖尿病酮症酸中毒:何时停止静脉滴注。
Cureus. 2022 Jan 31;14(1):e21768. doi: 10.7759/cureus.21768. eCollection 2022 Jan.
6
Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication.一名可卡因中毒患者的正常血糖性糖尿病酮症酸中毒
Case Rep Crit Care. 2016;2016:4275651. doi: 10.1155/2016/4275651. Epub 2016 Aug 8.
7
Euglycemic Diabetic Ketoacidosis: Experience with 44 Patients and Comparison to Hyperglycemic Diabetic Ketoacidosis.血糖正常的糖尿病酮症酸中毒:44 例患者的经验及与高血糖的糖尿病酮症酸中毒的比较。
West J Emerg Med. 2023 Nov;24(6):1049-1055. doi: 10.5811/westjem.60361.
8
Euglycemic diabetic ketoacidosis in the setting of acute intracerebral hemorrhage.急性脑出血背景下的正常血糖性糖尿病酮症酸中毒
Surg Neurol Int. 2024 Aug 16;15:284. doi: 10.25259/SNI_295_2024. eCollection 2024.
9
Euglycemic diabetic ketoacidosis.血糖正常的糖尿病酮症酸中毒。
Eur J Intern Med. 2019 May;63:9-14. doi: 10.1016/j.ejim.2019.03.014. Epub 2019 Mar 23.
10
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.与钠-葡萄糖协同转运蛋白2抑制剂使用相关的正常血糖性糖尿病酮症酸中毒:一例病例报告及文献综述
Int J Emerg Med. 2019 Sep 5;12(1):27. doi: 10.1186/s12245-019-0240-0.

引用本文的文献

1
[Sodium-Glucose Cotransporter-2 (SGLT-2) inhibitors in perioperative medicine : Effects, side effects and current recommendations].围手术期医学中的钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂:作用、副作用及当前建议
Anaesthesiologie. 2025 Sep 9. doi: 10.1007/s00101-025-01580-z.
2
Developing a Protocol for Management of Euglycemic Diabetic Ketoacidosis.制定正常血糖性糖尿病酮症酸中毒的管理方案。
Curr Diab Rep. 2025 Sep 3;25(1):48. doi: 10.1007/s11892-025-01604-3.
3
A Rare Case of Euglycemic Diabetic Ketoacidosis: Triad of Influenza A, Methicillin-Susceptible Staphylococcus aureus Pneumonia, and Sodium-Glucose Co-transporter 2 Inhibitor Use.

本文引用的文献

1
Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression.评估钠-葡萄糖共转运蛋白 (SGLT)-2 抑制剂在 1 型糖尿病患者中导致酮症酸中毒的风险:一项荟萃分析和荟萃回归。
PLoS Med. 2020 Dec 29;17(12):e1003461. doi: 10.1371/journal.pmed.1003461. eCollection 2020 Dec.
2
Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature.减重手术后使用钠-葡萄糖协同转运蛋白2抑制剂导致的正常血糖性糖尿病酮症酸中毒:文献综述
Cureus. 2020 Oct 10;12(10):e10878. doi: 10.7759/cureus.10878.
3
一例罕见的正常血糖性糖尿病酮症酸中毒病例:甲型流感、甲氧西林敏感金黄色葡萄球菌肺炎与钠-葡萄糖协同转运蛋白2抑制剂使用三联征
Cureus. 2025 Aug 24;17(8):e90882. doi: 10.7759/cureus.90882. eCollection 2025 Aug.
4
SGLT2 Inhibitors: From Structure-Effect Relationship to Pharmacological Response.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂:从构效关系到药理反应
Int J Mol Sci. 2025 Jul 19;26(14):6937. doi: 10.3390/ijms26146937.
5
Clinical features and outcomes of diabetic ketoacidosis in patients using SGLT2 inhibitors: A systematic review and meta-analysis.使用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的患者糖尿病酮症酸中毒的临床特征及结局:一项系统评价和荟萃分析
Diabetes Obes Metab. 2025 Oct;27(10):5805-5811. doi: 10.1111/dom.16635. Epub 2025 Jul 21.
6
Diabetes Mellitus in Pregnancy: Implications for Obstetric Anesthesia.妊娠糖尿病:对产科麻醉的影响
Anesthesiology. 2025 Aug 1;143(2):424-443. doi: 10.1097/ALN.0000000000005534. Epub 2025 Jul 8.
7
Euglycemic Diabetic Ketoacidosis in the Setting of Dulaglutide Use.使用度拉糖肽时出现的正常血糖性糖尿病酮症酸中毒
Cureus. 2025 Apr 12;17(4):e82143. doi: 10.7759/cureus.82143. eCollection 2025 Apr.
8
Construction and validation of nomogram prediction model for ketoacidosis in elderly diabetic patients based on baseline data and glycolipid metabolism.基于基线数据和糖脂代谢的老年糖尿病患者酮症酸中毒列线图预测模型的构建与验证
J Diabetes Investig. 2025 Jul;16(7):1338-1345. doi: 10.1111/jdi.70058. Epub 2025 May 7.
9
Unmasking Euglycemic Diabetic Ketoacidosis: The Interplay of Pregnancy, Sepsis, and Glucagon-Like Peptide 1 Analog.揭示正常血糖性糖尿病酮症酸中毒:妊娠、脓毒症与胰高血糖素样肽-1类似物之间的相互作用
Cureus. 2025 Jan 29;17(1):e78193. doi: 10.7759/cureus.78193. eCollection 2025 Jan.
10
Euglycemic Diabetic Ketoacidosis in a Pregnant Patient on Insulin Pump Therapy.胰岛素泵治疗的妊娠患者中的正常血糖性糖尿病酮症酸中毒
AACE Clin Case Rep. 2024 Oct 18;11(1):49-52. doi: 10.1016/j.aace.2024.10.004. eCollection 2025 Jan-Feb.
Euglycemic Diabetic Ketoacidosis Precipitated by a Keto Diet: Importance of Dietary History in Diagnosis.
生酮饮食诱发的正常血糖性糖尿病酮症酸中毒:饮食史在诊断中的重要性
Cureus. 2020 Sep 2;12(9):e10199. doi: 10.7759/cureus.10199.
4
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.钠-葡萄糖共转运蛋白 2 抑制剂与糖尿病酮症酸中毒风险:一项多中心队列研究。
Ann Intern Med. 2020 Sep 15;173(6):417-425. doi: 10.7326/M20-0289. Epub 2020 Jul 28.
5
Euglycemic Ketoacidosis.血糖正常的酮症酸中毒。
Curr Diab Rep. 2020 May 19;20(7):25. doi: 10.1007/s11892-020-01307-x.
6
A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketogenic Diet in a Patient With Type 2 Diabetes Using a Sodium-Glucose Cotransporter 2 Inhibitor.一名2型糖尿病患者使用钠-葡萄糖协同转运蛋白2抑制剂时,生酮饮食引发正常血糖性糖尿病酮症酸中毒一例。
Clin Diabetes. 2020 Apr;38(2):204-207. doi: 10.2337/cd19-0055.
7
Very restricted carbohydrate (ketogenic) diet: A rare cause of a recurrent hypoglycemic-euglycemic diabetic ketoacidosis in the pregnancy.极低碳水化合物(生酮)饮食:孕期复发性低血糖 - 血糖正常性糖尿病酮症酸中毒的罕见病因。
Eur J Obstet Gynecol Reprod Biol. 2020 May;248:257-258. doi: 10.1016/j.ejogrb.2020.03.021. Epub 2020 Mar 7.
8
SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂通过促进适应性细胞重编程诱导禁食模拟状态从而产生心肾保护作用:理解其作用机制的范式转变
Diabetes Care. 2020 Mar;43(3):508-511. doi: 10.2337/dci19-0074.
9
Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.在使用钠-葡萄糖协同转运蛋白2抑制剂治疗期间,因严格低碳水化合物饮食导致的正常血糖性糖尿病酮症酸中毒。
Acute Med Surg. 2020 Jan 16;7(1):e480. doi: 10.1002/ams2.480. eCollection 2020 Jan-Dec.
10
Euglycemic ketoacidosis induced by therapeutic fasting in a non-diabetic patient.非糖尿病患者在治疗性禁食期间发生的血糖正常性酮症酸中毒。
Nutrition. 2020 Apr;72:110668. doi: 10.1016/j.nut.2019.110668. Epub 2019 Dec 4.